These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 36442661

  • 1. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
    Li X, Yin X, Bao H, Liu C.
    Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 3. DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma.
    Zhang X, Wang W, Mo S, Sun X.
    Dig Dis Sci; 2024 Jun; 69(6):2096-2108. PubMed ID: 38653946
    [Abstract] [Full Text] [Related]

  • 4. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):52. PubMed ID: 29530052
    [Abstract] [Full Text] [Related]

  • 5. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
    Bao Y, Xu S, Zhou J, Zhao C, Dai S, Zhang Y, Rao M.
    J Biochem Mol Toxicol; 2024 Mar 12; 38(3):e23666. PubMed ID: 38375688
    [Abstract] [Full Text] [Related]

  • 6. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H, Zhang Q, Cui W, Li W, Zhang J.
    Cell Cycle; 2021 Oct 12; 20(20):2125-2136. PubMed ID: 34570663
    [Abstract] [Full Text] [Related]

  • 7. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.
    Guo X, Wang Z, Deng X, Lu Y, Huang X, Lin J, Lan X, Su Q, Wang C.
    Cell Cycle; 2022 Aug 12; 21(15):1557-1577. PubMed ID: 35400275
    [Abstract] [Full Text] [Related]

  • 8. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 12; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

  • 9. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W, Dong X, He C, Tan G, Li Z, Zhai B, Feng J, Jiang X, Liu C, Jiang H, Sun X.
    J Exp Clin Cancer Res; 2019 May 03; 38(1):183. PubMed ID: 31053148
    [Abstract] [Full Text] [Related]

  • 10. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.
    Int J Clin Exp Pathol; 2014 May 03; 7(7):4039-44. PubMed ID: 25120782
    [Abstract] [Full Text] [Related]

  • 11. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
    Lv B, Liu X, Zhu X, Huang M.
    World J Surg Oncol; 2022 Jun 02; 20(1):175. PubMed ID: 35655254
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH, Jin M, Wang LQ, Xu GJ, Lin ZY, Yu DD, Yang SL, Ran RZ, Wu G, Zhang T.
    J Cell Physiol; 2020 Sep 02; 235(9):6154-6166. PubMed ID: 32020591
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May 02; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1.
    Zhou Y, Huang Y, Dai T, Hua Z, Xu J, Lin Y, Han L, Yue X, Ho L, Lu J, Ai X.
    Biomed Pharmacother; 2021 Jan 02; 133():111030. PubMed ID: 33378944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.